logo
Free school meal expansion in England will benefit fewer than claimed, IFS says

Free school meal expansion in England will benefit fewer than claimed, IFS says

The Guardiana day ago

The expansion of free school meals will initially benefit far fewer children in England than claimed, according to the Institute for Fiscal Studies, as data shows more than one in four at state schools already receive free lunches.
The figures from the Department for Education's annual school census show that 25.7% of all pupils now receive free school meals (FSM), up by more than a percentage point compared with last year and nearly double the 13.6% in 2017.
The record of nearly 2.2 million children is an increase of 77,700 since January 2024.
The figures come as Bridget Phillipson, the education secretary, announced expanded FSM eligibility from September 2026, allowing all children from households receiving universal credit benefits to receive free lunches. Currently those with a net earned household income of below £7,400 a year are eligible.
While poverty campaigners and teaching unions welcomed Phillipson's announcement, the IFS said the expansion would take several years to affect levels of child poverty.
The IFS said in the long run it would lift 100,000 children out of poverty but 'in the short run, both the costs and the benefits of this policy are likely to be much smaller', because of the high proportion who already receive FSM.
Christine Farquharson, associate director at IFS, said: 'Transitional protections introduced in 2018 have substantially increased the number of children receiving free school meals today. So in the short run, today's announcement will both cost considerably less, around £250m a year, and benefit considerably fewer pupils [than the government's estimate of 500,000]. This also means that today's announcement will not see anything like 100,000 children lifted out of poverty next year.'
The previous government allowed transition arrangements in 2018, during the introduction of universal credit, to protect children receiving FSM and extend their eligibility. The transition ended in April this year, and would eventually have led to fewer children receiving FSM.
The IFS said: 'The ultimate impact of these transitional protections is that many more children are currently receiving free school meals than would otherwise be the case. This makes the short-run costs of expanding eligibility lower, but also means that fewer families will benefit on day one.'
Tammy Campbell of the Education Policy Institute noted that schools would not receive additional pupil premium funding for each child on FSM under the new extension. The funding, which ranges from £1,000 to £2,600 per pupil, will still be paid under the existing criteria including the £7,400 household income cap.
'There does not appear to be a clear rationale from government as to why the new free school meal eligibility criteria will not be reflected in pupil premium eligibility. The government is clear that these children are growing up in difficult circumstances. As such, they are more likely to have lower attainment and benefit from additional support in school,' Campbell said.
Phillipson also said the government would review school food standards. Speaking to the BBC Radio 4 Today programme, she said school food had not been looked at 'for a very long time' and that the government wanted to 'make sure that the food that's being served is healthy and nutritious'.
Henry Dimbleby, the restaurateur who chaired the last school food review in 2013, said a fresh review was overdue as some schools were not following existing standards. Campaigners have called for government guidance to encourage consumption of fruit, vegetables, and legumes and less use of processed meats.

Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

The ‘golden dose' of Mounjaro that experts warn could be deadly – as slimmers rave about it saving money
The ‘golden dose' of Mounjaro that experts warn could be deadly – as slimmers rave about it saving money

The Sun

time37 minutes ago

  • The Sun

The ‘golden dose' of Mounjaro that experts warn could be deadly – as slimmers rave about it saving money

A GROWING number of slimmers are trying to squeeze extra jabs out of empty Mounjaro pens in a risky bid to cut costs. The weight-loss injections, which can cost hundreds of pounds a month, are designed to deliver a fixed weekly dose. But online users claim there's still a small amount of drug left after the final shot. They say it can be drawn out with a syringe for a bonus jab, dubbed the 'golden dose'. One TikTok user claimed the trick saved her a fortune. By getting five jabs from a four-dose pen, users reckon they can claw back £615 a year. The reports come after NHS England said only a small number of people will be able to get Mounjaro from their GP. It means most people will still have to pay for it privately - which can cost hundreds of pounds a month. 'The drugs are expensive but weight loss is strongly desired, so as a commodity, these drugs are hotly sought-after,' said Professor Naveed Sattar, a cardiologist and obesity expert at the University of Glasgow, said. 'It's no surprise people are going to such extraordinary lengths," she told the inews. Medics say the DIY hack is dangerous and could lead to infection, overdose or death. "People are reading these tips on online forums and being tempted to use them to save money," said Professor Penny Ward, a pharmaceutical expert at King's College London. Women taking fat jabs need 'effective contraception' - as health chiefs warn of serious harm to unborn babies "But they're risking serious side effects from overdosing by doing this - as well as the potential to develop a life-threatening infection. "The potential to develop a life-threatening infection. It's not a good idea at all," she told MailOnline. Talk of the so-called 'golden dose' is also spreading on Reddit weight-loss forums. In one thread with more than 50 comments, a user wrote: "After four pumps of your uk injection pen they tell you to throw it away. "But there is an extra dose or thereabouts in the pen you can self inject with an insulin needle." Another replied saying: "Known much more on here as the fifth dose." 2 Slimmers have also taken to TikTok to rave about the 'discovery'. In one video, a nurse demonstrates how to use a needle to extract leftover medicine from the pen. She wrote: "I do not condone or encourage anybody to take their golden dose this is just what I am doing." Huge risks Professor Penny warned that this practice can be dangerous for "several" reasons. "These injections contain a slight overfill to ensure the full recommended dose is delivered each time," she said. "But by drawing this out with a separate syringe and using it as a so-called fifth dose, you're exposing yourself to serious risk of infection.' Once the pen has been used, it's no longer sterile, meaning any leftover liquid could be contaminated with harmful bacteria. Injecting it could lead to abscesses or, in extreme cases, life-threatening sepsis. There's also the danger of taking too much. 'If you're using your own syringe, it's difficult to measure the correct amount - you may end up taking more than intended,' she warned. Overdosing on the jab can trigger nasty side effects like vomiting and diarrhoea, or in rare cases, pancreatitis - a serious and painful condition that may need hospital treatment. Around one in five cases result in serious complications, with up to 30 per cent proving fatal. The risk rises sharply with higher doses, as the drug can trigger digestive enzymes that begin attacking the pancreas itself. Symptoms include sudden, severe tummy pain, often spreading to the back, along with fever, nausea and a racing heartbeat. "The bigger the dose, the bigger the risk of pancreatitis," Professor Ward warned. Everything you need to know about fat jabs Weight loss jabs are all the rage as studies and patient stories reveal they help people shed flab at almost unbelievable rates, as well as appearing to reduce the risk of serious diseases. Wegovy – a modified version of type 2 diabetes drug Ozempic – and Mounjaro are the leading weight loss injections used in the UK. Wegovy, real name semaglutide, has been used on the NHS for years while Mounjaro (tirzepatide) is a newer and more powerful addition to the market. Mounjaro accounts for most private prescriptions for weight loss and is set to join Wegovy as an NHS staple this year. How do they work? The jabs work by suppressing your appetite, making you eat less so your body burns fat for energy instead and you lose weight. They do this my mimicking a hormone called GLP-1, which signals to the brain when the stomach is full, so the drugs are officially called GLP-1 receptor agonists. They slow down digestion and increase insulin production, lowering blood sugar, which is why they were first developed to treat type 2 diabetes in which patients' sugar levels are too high. Can I get them? NHS prescriptions of weight loss drugs, mainly Wegovy and an older version called Saxenda (chemical name liraglutide), are controlled through specialist weight loss clinics. Typically a patient will have to have a body mass index (BMI) of 30 or higher, classifying them as medically obese, and also have a weight-related health condition such as high blood pressure. GPs generally do not prescribe the drugs for weight loss. Private prescribers offer the jabs, most commonly Mounjaro, to anyone who is obese (BMI of 30+) or overweight (BMI 25-30) with a weight-related health risk. Private pharmacies have been rapped for handing them out too easily and video calls or face-to-face appointments are now mandatory to check a patient is being truthful about their size and health. Are there any risks? Yes – side effects are common but most are relatively mild. Around half of people taking the drug experience gut issues, including sickness, bloating, acid reflux, constipation and diarrhoea. Dr Sarah Jarvis, GP and clinical consultant at said: 'One of the more uncommon side effects is severe acute pancreatitis, which is extremely painful and happens to one in 500 people.' Other uncommon side effects include altered taste, kidney problems, allergic reactions, gallbladder problems and hypoglycemia. Evidence has so far been inconclusive about whether the injections are damaging to patients' mental health. Figures obtained by The Sun show that, up to January 2025, 85 patient deaths in the UK were suspected to be linked to the medicines. Mounjaro - dubbed the "King Kong" of weight loss jabs - works by mimicking hormones released by the body when you're full. This makes people feel fuller for longer and therefore less hungry. It appears to be to be more potent than Wegovy - another popular weight loss jab - causing about 20 per cent weight loss after a year's use, compared with Wegovy's 15 per cent. Mounjaro's active ingredient is tirzepatide, a lab-made compound that mimics two gut hormones - GLP-1 and GIP - which help control blood sugar and appetite. This is why it was initially approved to treat diabetes type 2, which happens when people can't control their blood sugar. But in December 2024, it was also cleared for use on the NHS for weight loss in people with a BMI of over 30, or over 27 plus one weight-related condition. 'Excess solution' should be 'discarded' If you notice there is a considerable amount of medication left in your pen after the last dose, Professor Penny added, it may mean that you're not using the injection properly. "Speak to your pharmacist about your technique, or check that you definitely have the right size syringe, as this can impact the amount of medication left over," she said. A spokesperson for Lilly - the drug's manufacturer - said users should not do this, as the remaining liquid may not be a full dose. 'It is important to note that there will be a residual amount of medicine left after the fourth dose," they said. "This does not correspond to a full dose." 'Any excess solution in the pen after use should be discarded.' Dr Alison Cave, chief safety officer of the Medicines and Healthcare products Regulatory Agency, added: "Medicines are approved according to strict dosage guidelines. "Failure to adhere with these guidelines, such as tampering with pre-dosed injection pens, could harm your health or cause personal injury. "People should follow the dosing directions provided by their healthcare provider when prescribed weight-loss medicines and use as directed in the patient information leaflet." What are the other side effects of weight loss jabs? Like any medication, weight loss jabs can have side effects. Common side effects of injections such as Ozempic include: Nausea: This is the most commonly reported side effect, especially when first starting the medication. It often decreases over time as your body adjusts. Vomiting: Can occur, often in conjunction with nausea. Diarrhea: Some people experience gastrointestinal upset. Constipation: Some individuals may also experience constipation. Stomach pain or discomfort: Some people may experience abdominal pain or discomfort. Reduced appetite: This is often a desired effect for people using Ozempic for weight loss. Indigestion: Can cause a feeling of bloating or discomfort after eating. Serious side effects can also include: Pancreatitis: In rare cases, Ozempic may increase the risk of inflammation of the pancreas, known as pancreatitis, which can cause severe stomach pain, nausea, and vomiting. Kidney problems: There have been reports of kidney issues, including kidney failure, though this is uncommon. Thyroid tumors: There's a potential increased risk of thyroid cancer, although this risk is based on animal studies. It is not confirmed in humans, but people with a history of thyroid cancer should avoid Ozempic. Vision problems: Rapid changes in blood sugar levels may affect vision, and some people have reported blurry vision when taking Ozempic. Hypoglycemia (low blood sugar): Especially if used with other medications like sulfonylureas or insulin.

Who owns the news? It must not be a group of foreign powers
Who owns the news? It must not be a group of foreign powers

Telegraph

time38 minutes ago

  • Telegraph

Who owns the news? It must not be a group of foreign powers

Who owns the news? Much of the Left has been obsessed with the issue for over a century. They have long railed against press barons and their supposed bias. So it is perhaps surprising that this Labour Government is taking such a lackadaisical approach to foreign states having substantial holdings in British newspapers. The last Conservative government back in December 2023 intervened to put on hold and scrutinise the proposed sale of The Telegraph to a company backed by Sheikh Mansour, the deputy prime minister of the United Arab Emirates. Columnists, including Charles Moore, The Telegraph's former editor, rightly argued that even if there was no actual interference in the newspaper's editorial line, there would be the perception that the paper would no longer be independent. This would fatally undermine the newspaper's standing by throwing away its reputation for fearless reporting, whatever the reality of the situation. The then government listened and last year, in the Digital, Media and Competitions Act, introduced a new regulatory regime to restrict foreign state ownership of newspapers and news magazines. But this Act only set out the broad principle, not the details of how it would be implemented. A total ban would come with its own problems. There would be little risk of editorial interference if, say, the sovereign wealth fund of Norway was a passive investor owning 3pc or 4pc in a UK-listed media company. During the consultations, it was proposed that a 5pc limit may be appropriate to allow for such holdings. Last month the new Government announced that the threshold would not be 5pc, but actually 15pc. I and many of my colleagues in the House of Lords have serious misgivings about this much higher limit, but it is one we can live with. However, there is another aspect of the draft regulations which is unacceptable. The 15pc threshold is not cumulative, it applies to each individual holding. This means that there would be nothing to stop multiple states each owning 15pc of a newspaper. It has been reported that after The Telegraph's proposed takeover by RedBird Capital, Sheikh Mansour intends to retain up to a 15pc stake in the newspaper. With the current proposals there would be nothing to stop, say, Saudi Arabia, Oman and Bahrain from each taking 15pc holdings. A cumulative 60pc of a British newspaper owned by foreign states is a very different proposition. The guarantees against foreign control would have evaporated. Has this potential scenario arisen as a result of an oversight by Lisa Nandy, the Culture Secretary? Alongside 50 of my fellow peers, I have written to Ms Nandy asking for clarification. Signatories include former chancellor Lord Lamont, former trade secretary Lord Lilley, long-time chairman of the 1922 committee Lord Brady, ex-director of public prosecutions Lord Macdonald and the current chairman of Ipso, the independent press regulator, Lord Faulks. Our fears could be easily assuaged by simply amending the proposed regulations to ensure that 15pc is a cap on total foreign ownership. If the move is deliberate, it raises serious questions about this Government's commitment to a free press. The statutory instrument implementing the Government's regulations has now been laid and will shortly come before both Houses of Parliament. If the proposals reach the Lords in their current form, I and many of my colleagues will not be able to support the measure. The Telegraph's ownership has been left in limbo for two years so far. It is time for the new regulatory framework to be put in place that will allow its smooth transfer to new owners. But this must be done in a way that entrenches the traditional freedoms of our press. The issues are much wider than the future of just one newspaper.

‘Lots of bumps in the road': Keir Starmer faces testing month before one-year milestone
‘Lots of bumps in the road': Keir Starmer faces testing month before one-year milestone

The Guardian

time42 minutes ago

  • The Guardian

‘Lots of bumps in the road': Keir Starmer faces testing month before one-year milestone

As Keir Starmer approaches his first anniversary in Downing Street, there will be several things he wishes he had done differently. But before he can contemplate that July milestone, he faces a busy month strewn with political bear traps. June has proven a difficult time for successive prime ministers: Theresa May, Boris Johnson and Rishi Sunak all had to contend with deeply unhappy parliamentary parties reeling from heavy local and European election losses. While the mood among Labour MPs is nowhere near as mutinous, they too are bruised from a difficult set of local election results in England in May and the surge of Reform UK. 'There is more than the usual amount of grumbling and discontent,' a government source said. One unexpected ray of light was the result of the Holyrood byelection in Hamilton, Larkhall and Stonehouse on Friday. Labour secured a surprise victory, knocking the Scottish National party into second place and restoring some hope in Labour's fortunes ahead of next year's Holyrood elections. One MP said the result was 'humiliating' for the SNP. It is certainly a welcome win for Downing Street as Labour MPs brace for more bad news and a series of contentious debates this month. 'They know that the spending review is going to be really hard,' a government source said. The spending review on 11 June, which will set out multi-year departmental budgets after months of tense negotiations between the Treasury and cabinet ministers, will be a make-or-break moment for Starmer and his chancellor, Rachel Reeves. Downing Street is trying to grasp the nettle by putting plans for capital investment in underserved parts of the country at the centre of the narrative. But government strategists are braced for a wave of discontent once the data tables are published revealing cuts across unprotected departments. The most highly anticipated parliamentary moment is the first Commons vote on the government's welfare measures, including deep cuts to disability benefits. Labour whips are seeking to minimise the size of the rebellion after dozens of MPs signed a letter saying they found the proposals impossible to support. Officials say the vote will take place in the second half of June and have repeatedly denied rumours that it could be delayed to the autumn. Officials have also pencilled in the publication of a number of government strategies and reviews that have the potential to draw backlash. The delayed China audit, which fulfils a Labour manifesto commitment to appraise China's role in UK supply chains and what challenges and opportunities that poses, is due later this month. Downing Street is sensitive to criticism over its rapprochement with Beijing, which will come under scrutiny as a number of Chinese ministers and officials arrive in the UK on official trips this month. One question relates to China's place in the foreign influence registration scheme, which remains unresolved amid long-running tensions between the Treasury and the Home Office. The government also plans to publish its industrial strategy in the second half of June. Strategists see this document as key to Labour's political fightback against Nigel Farage and want to use it to build the narrative of drumming up investment after the spending review, including in defence. Earlier in the spring there were murmurings among business figures and government insiders who feared the document would be underwhelming and that Jonathan Reynolds, the business secretary, had been too busy negotiating a succession of trade deals with the US, EU and India. Ministers have been warned that the strategy must set out a plan to reduce the UK's high energy costs for companies, on the basis that these are a major obstacle to growth. Finally, the government's 10-year plan for the NHS in England is expected either in late June or in July, and is also considered key to Labour's electoral prospects. It is expected to set out plans to improve the NHS app. In the Commons there are three crunch votes expected to take place this month. One is over the assisted dying bill sponsored by the Labour backbencher Kim Leadbeater, which seeks to give terminally ill people with less than six months left the right to end their own lives. The proposed legislation has opened a bitter divide in the parliamentary Labour party and sparked concerns in Downing Street that arguments over the bill are distracting from the government's core agenda. Starmer, who in the past has expressed support for changing the law, voted in favour of the bill at its second reading and indicated recently that his position hadn't changed. The Commons will consider amendments to the bill on 13 June and is expected to vote on it again on 20 June. Another difficult moral question due to be considered by MPs this month is whether to decriminalise abortion in England and Wales. Several women in recent years have found themselves in the dock for ending their pregnancies outside the strict legal parameters of the Abortion Act 1967. Two Labour backbenchers are putting forward amendments to the crime and policing bill, which is due to return to the Commons in a fortnight. 'There's lots of little bumps in the road – it's quite an important few weeks,' a Labour source said. The upside for Starmer is that if he succeeds in overcoming this series of hurdles fairly smoothly, the mood in government and the PLP will start to improve before summer recess. If he doesn't, any celebrations to mark his first year in power will be pretty muted.

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into the world of global news and events? Download our app today from your preferred app store and start exploring.
app-storeplay-store